Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

7.30

+0.19 (2.67%)

At close: May 13, 2025, 4:00 PM

8.00

+0.70 (9.59%)

Pre-market: May 14, 2025, 4:01 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Transformative Cell and Exosome-based Therapeutics	25.18M	Log In	Log In	Log In	Log In	Upgrade
Transformative Cell and Exosome-based Therapeutics Growth	886.81%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	25.18M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	886.81%	Log In	Log In	Log In	Log In	Upgrade